Protagenic Therapeutics Inc. (PTIX): Share Price, Stock Analysis, Annual Report | Value Research Get Protagenic Therapeutics Inc. (PTIX)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

  • Healthcare
  • Biotechnology & Pharma Research

Protagenic Therapeutics Inc. (PTIX)

NASDAQ: PTIX

  • Market Capitalisation info

    $12 Mln


  • 12 Month Earnings info

    $-5 Mln

  • Price to Earnings info

    --

$0.69

As on 17-Aug-2022 12:30 EDT

up-down-arrow $0.000.03%

  • Prev Close info

    $0.69

  • Day's Openinfo

    $0.69

  • Today's Highinfo

    $0.69

  • Today's Lowinfo

    $0.68

  • Today's Volumeinfo

    988

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Protagenic Therapeutics (PTIX)
-50.27 11.08 -0.92 -60.65 -- -- -37.87
S&P BSE Sensex
3.44 12.09 13.75 8.42 17.29 13.66 13.06
S&P Small-Cap 600
-8.42 12.89 8.31 -4.42 11.76 8.97 10.87
As on 17-Aug-2022
2021
2020
2015
Protagenic Therapeutics (PTIX)
31.90 -25.54 -83.33
S&P Small-Cap 600
25.27 9.57 -3.36
S&P BSE Sensex
21.99 15.75 -5.03

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other Details

        Co-Founder & Exec. Chairman

        Dr. Garo H. Armen Ph.D.

        CFO & Sec.

        Dr. Alexander Kenneth Arrow C.F.A., M.D.

        Headquarters

        New York, NY
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          $11.71 Mln

        • Revenue (TTM) info

          $0.00 Mln

        • Earnings (TTM) info

          $-4.68 Mln

        • Cash info

          $10.37 Mln

        • Total Debt info

          $0.50 Mln

        • Insider's Holding

          19.57%

        • Liquidity info

          Low

        • 52 Week range info

          $0.56 - 2.35

        • Shares outstanding info

          17,285,300

        • 10 Years Aggregate:

          CFO: $-10.72 Mln

          EBITDA: $-17.52 Mln

          Net Profit: $-19.87 Mln

        About The Company

        • Business

          Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders.

        • IPO Date

          05-Jan-2016

        • Co-Founder & Exec. Chairman

          Dr. Garo H. Armen Ph.D.

        • CFO & Sec.

          Dr. Alexander Kenneth Arrow C.F.A., M.D.

        • Listing info

          NASDAQ: PTIX

        • Country

          United States

        • Headquarters info

          New York, NY

        • Website info

          https://www.protagenic.com